Characterisation of the beta adrenergic response cascade in fetal guinea pig lung

BACKGROUND--Suitable models for the study of lung development are needed. The suitability of the guinea pig for studying the role of the beta adrenergic response cascade in fetal lung development has been evaluated. METHODS--Radioligand binding assays with iodine-125 labelled iodopindolol were perfo...

Full description

Saved in:
Bibliographic Details
Published in:Thorax Vol. 49; no. 7; pp. 664 - 669
Main Authors: Lyon, M E, Lefebvre, C A, Davis, D J
Format: Journal Article
Language:English
Published: London BMJ Publishing Group Ltd and British Thoracic Society 01-07-1994
BMJ
BMJ Publishing Group LTD
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUND--Suitable models for the study of lung development are needed. The suitability of the guinea pig for studying the role of the beta adrenergic response cascade in fetal lung development has been evaluated. METHODS--Radioligand binding assays with iodine-125 labelled iodopindolol were performed to identify and characterise the beta adrenergic receptors. To demonstrate that these receptors were functional, isoprenaline and forskolin stimulated generation of cyclic AMP (cAMP) in the lung tissue was quantitated by radioimmunoassay. RESULTS--The concentration of beta receptors increased with gestational age from 23 fmol/mg at 35 days to 140 fmol/mg at 64 days. Competition binding studies were consistent with a predominance of beta 2 receptors. The ability of isoprenaline to stimulate cAMP generation was greater during the saccular phase than during the canalicular phase of lung development. Incorporation of tritium labelled choline into phosphatidylcholine increased significantly between the canalicular and saccular phases. CONCLUSIONS--The beta adrenergic response cascade in fetal guinea pig lung exhibits similar characteristics to those previously described in fetal human lung and is therefore a good model in which to study the effects of beta agonists on fetal lung development.
Bibliography:local:thoraxjnl;49/7/664
href:thoraxjnl-49-664.pdf
ark:/67375/NVC-1BSSGS9G-0
PMID:7915050
istex:60A665208F4A2464D2A848CEE234F880B1C39795
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0040-6376
1468-3296
DOI:10.1136/thx.49.7.664